Frequency Research Development from 2010 to 2026
| KRRO Stock | 11.54 0.72 5.87% |
Research Development | First Reported 2019-09-30 | Previous Quarter 21 M | Current Value 13.8 M | Quarterly Volatility 4.1 M |
Check Frequency Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Frequency Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 128.9 K or Gross Profit of 1.9 M, as well as many indicators such as Price To Sales Ratio of 141, Dividend Yield of 0.0 or PTB Ratio of 2.0. Frequency financial statements analysis is a perfect complement when working with Frequency Therapeutics Valuation or Volatility modules.
Frequency | Research Development | Build AI portfolio with Frequency Stock |
Evaluating Frequency Therapeutics's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Frequency Therapeutics's fundamental strength.
Latest Frequency Therapeutics' Research Development Growth Pattern
Below is the plot of the Research Development of Frequency Therapeutics over the last few years. It is Frequency Therapeutics' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Frequency Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Frequency Research Development Regression Statistics
| Arithmetic Mean | 29,282,698 | |
| Geometric Mean | 22,245,170 | |
| Coefficient Of Variation | 76.56 | |
| Mean Deviation | 19,838,233 | |
| Median | 11,786,000 | |
| Standard Deviation | 22,418,226 | |
| Sample Variance | 502.6T | |
| Range | 61.6M | |
| R-Value | 0.84 | |
| Mean Square Error | 155.9T | |
| R-Squared | 0.71 | |
| Significance | 0.000022 | |
| Slope | 3,738,494 | |
| Total Sum of Squares | 8041.2T |
Frequency Research Development History
About Frequency Therapeutics Financial Statements
Frequency Therapeutics investors utilize fundamental indicators, such as Research Development, to predict how Frequency Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 73.2 M | 41.4 M |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.6 | DSGN | Design Therapeutics | PairCorr |
| 0.4 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.36 | ENGN | enGene Holdings Common | PairCorr |
| 0.32 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.31 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Frequency Therapeutics Correlation against competitors. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Frequency diversify its offerings? Factors like these will boost the valuation of Frequency Therapeutics. Expected growth trajectory for Frequency significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Frequency Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Frequency Therapeutics requires distinguishing between market price and book value, where the latter reflects Frequency's accounting equity. The concept of intrinsic value - what Frequency Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Frequency Therapeutics' price substantially above or below its fundamental value.
Understanding that Frequency Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Frequency Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Frequency Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.